dc.creatorMorales, Javier O.
dc.creatorMcConville, Jason T.
dc.date.accessioned2019-03-15T16:06:37Z
dc.date.available2019-03-15T16:06:37Z
dc.date.created2019-03-15T16:06:37Z
dc.date.issued2014
dc.identifierDrug Development and Industrial Pharmacy, Volumen 40, Issue 5, 2018, Pages 579-590
dc.identifier15205762
dc.identifier03639045
dc.identifier10.3109/03639045.2014.892960
dc.identifierhttps://repositorio.uchile.cl/handle/2250/166166
dc.description.abstractFor years now, the delivery of small molecules through the buccal mucosal route has been described in the literature, but it has only been over the past decade that investigations into macromolecule delivery via the buccal route have sharply increased. The administration of macromolecules such as proteins and peptides, antibodies, or nucleic acids by buccal administration would be greatly enhanced due to the avoidance of the gastrointestinal conditions, rapid uptake into systemic circulation, as well as the potential for controlled drug delivery. Since macromolecules are faced with a number of specific challenges related to permeation through the epithelium, several strategies have been employed historically to improve their buccal absorption and subsequent bioavailability. Several conventional strategies to improve macromolecule penetration include the use of chemical permeation enhancers, enzyme inhibitors and the use of mucoadhesive materials acting as carriers. More recent approach
dc.languageen
dc.publisherInforma Healthcare
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceDrug Development and Industrial Pharmacy
dc.subjectBuccal delivery
dc.subjectMacromolecule delivery
dc.subjectMucoadhesion
dc.subjectNanoparticle
dc.subjectPeptide and protein delivery
dc.subjectPermeation enhancement
dc.titleNovel strategies for the buccal delivery of macromolecules
dc.typeArtículo de revista


Este ítem pertenece a la siguiente institución